| Literature DB >> 35774059 |
Andreea-Cristina Mirica1,2, Dana Stan1, Ioana-Cristina Chelcea1, Carmen Marinela Mihailescu3,4, Augustin Ofiteru1, Lorena-Andreea Bocancia-Mateescu1.
Abstract
LFIA is one of the most successful analytical methods for various target molecules detection. As a recent example, LFIA tests have played an important role in mitigating the effects of the global pandemic with SARS-COV-2, due to their ability to rapidly detect infected individuals and stop further spreading of the virus. For this reason, researchers around the world have done tremendous efforts to improve their sensibility and specificity. The development of LFIA has many sensitive steps, but some of the most important ones are choosing the proper labeling probes, the functionalization method and the conjugation process. There are a series of labeling probes described in the specialized literature, such as gold nanoparticles (GNP), latex particles (LP), magnetic nanoparticles (MNP), quantum dots (QDs) and more recently carbon, silica and europium nanoparticles. The current review aims to present some of the most recent and promising methods for the functionalization of the labeling probes and the conjugation with biomolecules, such as antibodies and antigens. The last chapter is dedicated to a selection of conjugation protocols, applicable to various types of nanoparticles (GNPs, QDs, magnetic nanoparticles, carbon nanoparticles, silica and europium nanoparticles).Entities:
Keywords: LFIA; bioconjugation; diagnostic; functionalization; nanoparticles
Year: 2022 PMID: 35774059 PMCID: PMC9237331 DOI: 10.3389/fbioe.2022.922772
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1The operation principle of LFIA sandwich-based method (Created with BioRender.com).
Pros and cons of the synthesis methods for each type of detection label.
| Detection label | Synthesis method | Advantages | Disadvantages |
|---|---|---|---|
| GNPs | Turkevich-Frens method | - simple and reproducible technique | - GNPs with a diameter greater than 30 nm lose their spherical shape; |
| - stable GNPs with controlled size are obtained | - at suboptimal reagent concentrations, pH, or temperatures, GNPs lose their stability | ||
| - the method is applicable to a wide range of precursors | |||
| Green synthesis | - more environmentally friendly | - involves several steps in the synthesis in general, as it adds the step of extracting the active compound from the CAS | |
| - it is a rapid and low-cost method | - it is difficult to determine which are the reactive compounds in the extract | ||
| - reaction parameters are much easier to control | |||
| LMPs | Seed emulsion polymerization | - products are obtained in latex form that is ready for use | - if excessive amounts of seeds are added, bimodal latexes with low viscosity can form |
| - the latex particles obtained are more stable | - surfactants and other additives remain on the particle surface and are difficult to remove | ||
| - organic compounds increase toxicity | |||
| Emulsifier-free emulsion polymerization | - the absence of an emulsifier eliminates the risk of undesired contamination in the particles obtained | - larger diameter particles are obtained due to the hydration layer on the surface | |
| - synthesis involves a single step | |||
| - spherical, monodisperse microparticles are obtained | |||
| MNPs | Co-precipitation | - is an efficient method | - washing, drying, and calcining cycles are required to obtain a pure compound |
| - the process can be easily controlled | - pH adjustment may be necessary | ||
| - particles of well-defined size and properties are obtained | |||
| Hydrothermal synthesis | - a process that occurs with excellent control over the size and shape of nanoparticles | - requires high temperature and vapor pressure | |
| - involves minimal waste | - require expensive equipment and installations | ||
| Green synthesis | - the reducing agent is a natural compound | - to obtain larger particle diameters, the reaction time increases | |
| - exhibits low toxicity | |||
| QDs | CdSe synthesis | - synthesis occurs at room temperature | - increased cadmium toxicity |
| - stability is improved | |||
| InAs synthesis | - pyrophoric precursors are not required | - some of the compounds involved are highly toxic | |
| - In(I)Cl is used both as a reducing agent and as a source of indium | |||
| CdTe synthesis—green synthesis | - the extraction method of the reactive natural compound has been shown to be useful for other nanoparticle syntheses | - requires nitrogen atmosphere | |
| - it is a fast and efficient method | - cadmium is highly toxic | ||
| CNPs | Laser ablation of graphite | - nanoparticle size can be controlled | - use of the equipment requires qualified operators |
| - good dispersity is achieved | - the cost of the equipment is high | ||
| - high efficiency | |||
| Chemical vapor deposition | - high purity particles are achieved | - secondary reaction products are highly toxic | |
| - low pressure is required | - nanoparticle deposition is achieved at high temperatures | ||
| Carbonization | - the process can be easily controlled | - requires nanoparticle purification | |
| - biological precursors are used | - sodium phosphate has negative effects on the human organism | ||
| SiNPs | Stöber method | - occurs at room temperature | - ammonia, used as a catalyst, is highly toxic |
| - monodisperse nanoparticles are obtained | |||
| Green synthesis | - the final compound obtained reaches a purity of 90–96% | - method involves two steps | |
| - exhibits low toxicity | - purification of the nanoparticles is required | ||
| EuNPs | Colloidal precipitation method | - is a versatile method | - reaction waste products are a negative factor for the environment |
| - the method requires mild synthesis conditions | - the method is limited regarding the size of the nanoparticles obtained | ||
| Green synthesis | - more environmentally friendly | - nanoparticles obtained are not well dispersed | |
| - crystalline nanoparticles are produced | - requires purification steps |
FIGURE 2Physical adsorption of antibodies to the surface of citrate stabilized GNP, according to pH (Created with BioRender.com).
FIGURE 3Schematic representation of the conjugation process mediated by the functional groups on the surface of the nanoparticle: (A) EDC/NHS mediated coupling of -COOH covered nanoparticle with antibody; (B) EDC/NHS mediated coupling of NH2 covered nanoparticle with antibody; (C) glutaraldehyde coupling of -OH covered nanoparticle to antibody (Created with BioRender.com).
FIGURE 4Schematic representation of the conjugation process using chemically modified antibodies: (A) Thiol modified antibody coupling with gold nanoparticle; (B) EDC/NHS mediated coupling of antibody -COOH with NH2 covered nanoparticle (Created with BioRender.com).
FIGURE 5Schematic representation of the conjugation process using chemically modified detection molecule and labeling probe (Created with BioRender.com).
Binding types and their effect on the conjugate quality and overall sensitivity of LFIA.
| Type of interaction | Particle | Effect | Target | LOD | References |
|---|---|---|---|---|---|
| Electrostatic interaction | Gold nanoparticle | High rate of bound antibody, but poor orientation | 17β-estradiol | 500 ng/ml |
|
| Covalent binding | Gold nanoparticle | Lower rate o bound antibody, with good orientation | 17β-estradiol | 200 ng/ml | |
| Physical adsorption | Gold nanoparticle | Not available |
| 104 CFU/ml |
|
| Physical adsorption | Au core—Pt shell nanoparticle | Not available |
| 103 CFU/ml | |
| Covalent binding | Latex nanoparticle | Not available |
| 104 CFU/ml | |
| Covalent binding | Magnetic nanoparticle | Not available |
| 105 CFU/ml | |
| Streptavidin-biotin coupling | Gold nanoparticle | Increased sensitivity for the larger particles (35–50 nm) |
| 101 CFU/ml |
|
|
| |||||
| Physical adsorption (nanobodies) | Gold nanoparticle | Salt induced aggregation | Not available | Not available |
|
| Physical adsorption | Carbon nanoparticle | Stable conjugates | Influenza A | 3.5 × 102 TCID50 mL−1 |
|
| Covalent binding | Gold nanoparticle | Au-S bound | Staphylococcal enterotoxin A | 5 ng/ml |
|
| Covalent binding | Gold nanoparticle | Bound between surface alkyne and azido modified proteins | Not available | Not available |
|
| Physical adsorption | Carbon nanoparticle | Not available | β–lactams | 1–30 ng/ml for most antibiotics and 100 ng/ml cephalexin |
|
| Covalent binding | Europium III chelate nanoparticle | The binding of the protein did not affect the optical properties | Cystatin C | 24,54 ng/ml |
|
| Covalent binding | Latex microparticles | Not available | Bisphenol A | 10 ng/ml |
|